|
1.
|
Koomoa DL, Geerts D, Lange I, Koster J, Pegg AE, Feith DJ, Bachmann AS. DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma. Int J Oncol. 2013 Apr; 42(4):1219-28.
|
|
|
|
|
2.
|
Feith DJ, Pegg AE, Fong LY. Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient mice. Carcinogenesis. 2013 Mar; 34(3):570-6.
|
|
|
|
|
3.
|
Shi C, Cooper TK, McCloskey DE, Glick AB, Shantz LM, Feith DJ. S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion. Carcinogenesis. 2012 Jul; 33(7):1310-8.
|
|
|
|
|
4.
|
Welsh PA, Sass-Kuhn S, Prakashagowda C, McCloskey D, Feith D. Spermine synthase overexpression in vivo does not increase susceptibility to DMBA/TPA skin carcinogenesis or Min-Apc intestinal tumorigenesis. Cancer Biol Ther. 2012 Apr; 13(6):358-68.
|
|
|
|
|
5.
|
Shi C, Welsh PA, Sass-Kuhn S, Wang X, McCloskey DE, Pegg AE, Feith DJ. Characterization of transgenic mice with overexpression of spermidine synthase. Amino Acids. 2012 Feb; 42(2-3):495-505.
|
|
|
|
|
6.
|
Feith DJ. Carcinogenesis studies in mice with genetically engineered alterations in polyamine metabolism. Methods Mol Biol. 2011; 720:129-41.
|
|
|
|
|
7.
|
Geerts D, Koster J, Albert D, Koomoa DL, Feith DJ, Pegg AE, Volckmann R, Caron H, Versteeg R, Bachmann AS. The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification. Int J Cancer. 2010 May 1; 126(9):2012-24.
|
|
|
|
|
8.
|
Koomoa DL, Borsics T, Feith DJ, Coleman CC, Wallick CJ, Gamper I, Pegg AE, Bachmann AS. Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma. Mol Cancer Ther. 2009 Jul; 8(7):2067-75.
|
|
|
|
|
9.
|
Wang X, Feith DJ, Welsh P, Coleman CS, Lopez C, Woster PM, O'Brien TG, Pegg AE. Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis. Carcinogenesis. 2007 Nov; 28(11):2404-11.
|
|
|
|
|
10.
|
Feith DJ, Shantz LM, Shoop PL, Keefer KA, Prakashagowda C, Pegg AE. Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds. Mol Carcinog. 2007 Jun; 46(6):453-65.
|
|
|
|
|
11.
|
Pegg AE, Feith DJ. Polyamines and neoplastic growth. Biochem Soc Trans. 2007 Apr; 35(Pt 2):295-9.
|
|
|
|
|
12.
|
Feith DJ, Origanti S, Shoop PL, Sass-Kuhn S, Shantz LM. Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis. Carcinogenesis. 2006 May; 27(5):1090-8.
|
|
|
|
|
13.
|
Wallick CJ, Gamper I, Thorne M, Feith DJ, Takasaki KY, Wilson SM, Seki JA, Pegg AE, Byus CV, Bachmann AS. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells. Oncogene. 2005 Aug 25; 24(36):5606-18.
|
|
|
|
|
14.
|
Feith DJ, Bol DK, Carboni JM, Lynch MJ, Sass-Kuhn S, Shoop PL, Shantz LM. Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis. Cancer Res. 2005 Jan 15; 65(2):572-8.
|
|
|
|
|
15.
|
Tang X, Kim AL, Feith DJ, Pegg AE, Russo J, Zhang H, Aszterbaum M, Kopelovich L, Epstein EH, Bickers DR, Athar M. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice. J Clin Invest. 2004 Mar; 113(6):867-75.
|
|
|
|
|
16.
|
Fong LY, Feith DJ, Pegg AE. Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis. Cancer Res. 2003 Jul 15; 63(14):3945-54.
|
|
|
|
|
17.
|
Pegg AE, Feith DJ, Fong LY, Coleman CS, O'Brien TG, Shantz LM. Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth. Biochem Soc Trans. 2003 Apr; 31(2):356-60.
|
|
|
|
|
18.
|
Shantz LM, Feith DJ, Pegg AE. Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy. Biochem J. 2001 Aug 15; 358(Pt 1):25-32.
|
|
|
|
|
19.
|
Feith DJ, Shantz LM, Pegg AE. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Cancer Res. 2001 Aug 15; 61(16):6073-81.
|
|
|
|
|
20.
|
Mackintosh CA, Feith DJ, Shantz LM, Pegg AE. Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy. Biochem J. 2000 Sep 15; 350 Pt 3:645-53.
|
|
|
|
|
21.
|
Pegg AE, Xiong H, Feith DJ, Shantz LM. S-adenosylmethionine decarboxylase: structure, function and regulation by polyamines. Biochem Soc Trans. 1998 Nov; 26(4):580-6.
|
|
|
|
|
22.
|
Matés JM, del Valle AE, Urdiales JL, Coleman CS, Feith D, Olmo MT, Pegg AE, Sánchez-Jiménez F. Structure/function relationship studies on the T/S residues 173-177 of rat ODC. Biochim Biophys Acta. 1998 Jul 28; 1386(1):113-20.
|
|
|
|